Personal information

Activities

Works (4)

KIR3DL1-HLA-Bw status in CML is associated with achievement of TFR: the POKSTIC trial, a multicenter observational study

Blood Neoplasia
2024-03 | Journal article
Contributors: Hiroshi Ureshino; Yasunori Ueda; Shin Fujisawa; Kensuke Usuki; Hideo Tanaka; Masaya Okada; Shugo Kowata; Kazunori Murai; Asao Hirose; Motohiro Shindo et al.
Source: check_circle
Crossref

Rapid reduction in BCR‐ABL1 transcript predicts deep molecular response in dasatinib‐treated chronic‐phase chronic myeloid leukaemia patients

European Journal of Haematology
2018-01 | Journal article
Contributors: Kazunori Murai; Kohei Yamaguchi; Shigeki Ito; Takuto Miyagishima; Motohiro Shindo; Kentaro Wakasa; Mitsue Inomata; Takahiro Nagashima; Takeshi Kondo; Nozomu Fujimoto et al.
Source: check_circle
Crossref

A prospective analysis of clinical efficacy and safety in chronic myeloid leukemia-chronic phase patients with imatinib resistance or intolerance as evaluated using European LeukemiaNet 2013 criteria.

2015-12 | Journal article
Source: Self-asserted source
Kazunori Murai

Bortezomib induces thrombocytopenia by the inhibition of proplatelet formation of megakaryocytes.

2014-10 | Journal article
Source: Self-asserted source
Kazunori Murai